 Physiology pharmacology cardiovascular catecholamine receptors implications treatment chronic heart failure sympathetic nervous system physiologic effects endogenous catecholamines noradrenaline NA adrenaline alpha- beta-adrenoreceptors ARs AR-types major subtypes alpha-ARs predominant effect vasoconstriction presynaptic inhibition NA-release postsynaptic vasoconstriction beta-ARs cardiac effects renal renin release lipolysis presynaptic facilitation NA-release postsynaptic vascular bronchial uterine smooth muscle relaxation glycogenolysis part A-mediated cardiac effects last years evidence dopamine DA third endogenous catecholamine immediate precursor NA peripheral effects stimulation specific DA-receptors addition action alpha- beta-ARs different DA-receptors present many peripheral tissues cardiovascular autonomic nervous system dilation certain vascular beds inhibition NA-release nerve stimulation natriuresis aldosterone release chronic heart failure cardiac beta-AR function decreases endogenous down-regulation elevated catecholamines decrease severity heart failure New York Heart Association functional class human heart functional ARs cardiac ARs different kinds heart failure end-stage cardiomyopathy ARs ARs normal